Handbook of brain tumor chemotherapy.

Saved in:
Bibliographic Details
Edition:1st ed.
Imprint:Amsterdam ; San Diego : Elsevier/Academic Press, 2006.
Description:xvi, 510 p., [24] p. of plates ; 29 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5930637
Hidden Bibliographic Details
Other authors / contributors:Newton, Herbert B.
ISBN:0120884100

MARC

LEADER 00000nam a2200000 4500
001 5930637
003 ICU
005 20080514102700.0
008 060130s2006 ne eng d
020 |a 0120884100 
035 |a (OCoLC)63536643 
040 |a NhCcYBP  |c NhCcYBP  |d OrLoB-B  |d UtOrBLW 
050 4 |a RC280.B7  |b H36 2006 
245 0 0 |a Handbook of brain tumor chemotherapy. 
250 |a 1st ed. 
260 |a Amsterdam ;  |a San Diego :  |b Elsevier/Academic Press,  |c 2006. 
300 |a xvi, 510 p., [24] p. of plates ;  |c 29 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
505 0 0 |g 1.  |t Overview of brain tumor epidemiology and histopathology /  |r Herbert B. Newton and Abhik Ray-Chaudhury --  |g 2.  |t Clinical pharmacology of brain tumor chemotherapy /  |r Herbert B. Newton --  |g 3.  |t Chemotherapy and anti-epileptic drug interactions /  |r Karen L. Fink --  |g 4.  |t Brain tumor models for cancer therapy /  |r Beverly A. Teicher --  |g 5.  |t Microarray analysis and proteomic approaches to drug development /  |r Nicole J. Ullrich and Scott L. Pomeroy --  |g 6.  |t Chemotherapy resistance /  |r Adrienne C. Scheck --  |g 7.  |t Clinical trial deign and implementation /  |r Nicholas Butowski and Susan Chang --  |g 8.  |t Molecular genetics of brain tumors - an overview /  |r Tim Demuth and Michael E. Berens --  |g 9.  |t Regulation of the cell cycle and interventional developmental therapeutics /  |r Stacey M. Ivanchuk and James T. Rutka --  |g 10.  |t Apoptosis pathways and chemotherapy /  |r Joachim P. Steinbach and Michael Weller --  |g 11.  |t Growth factor signaling pathways and receptor tyrosine kinase inhibitors /  |r Ian F. Pollack --  |g 12.  |t Ras signaling pathways and farnesyl transferase inhibitors /  |r Joydeep Mukherjee and Abhijit Guha --  |g 13.  |t PI3-kinase, PKB/Akt, mTOR, and internal signaling pathways /  |r Jean L. Nakamura and Daphne A. Haas-Kogan --  |g 14.  |t Tumor invasiveness and anti-invasion strategies /  |r Sandra A. Rempel and Tom Mikkelsen --  |g 15.  |t Mechanisms of angiogenesis in brain tumors and their translation into therapeutic anti-tumor strategies /  |r Till Acker and Karl H. Plate --  |g 16.  |t Biology of the blood-brain and blood-brain tumor barriers /  |r Herbert H. Engelhard and Tibor Valyi-Nagy --  |g 17.  |t Intra-arterial chemotherapy /  |r Herbert B. Newton --  |g 18.  |t Blood-brain barrier disruption chemotherapy /  |r Nancy D. Doolittle, Tulio P. Murillo and Edward A. Neuwelt --  |g 19.  |t Interstitial chemotherapy and polymer-drug delivery /  |r Raqeeb M. Haque, Eric Amundson, Michael Dorsi and Henry Brem --  |g 20.  |t Intratumoral administration and convection-enhanced delivery /  |r Mike Yue Chen, Zhi-Jian Chen, George T. Gillies, Peter J. Haar and Wiliam C. Broaddus --  |g 21.  |t Marrow ablative chemotherapy with hematopoietic stem cell rescue /  |r Anna Butturini, Matthew Carabasi and Jonathan L. Finlay --  |g 22.  |t CSF dissemination of primary brain tumors /  |r Marc C. Chamberlain --  |g 23.  |t Chemotherapy-activating gene therapy /  |r Kaveh Asadi-Moghaddam and Antonio E. Echocca --  |g 24.  |t Chemotherapy of high-grade astrocytomas /  |r Herbert B. Newton --  |g 25.  |t Chemotherapy of low-grade astrocytomas /  |r Mark G. Malkin --  |g 26.  |t Chemotherapy of oligodendrogliomas /  |r Nina A. Paleologos and Christopher Fahey --  |g 27.  |t Chemotherapy of oligoastrocytomas /  |r Allison L. Weathers and Nina A. Paleologos --  |g 28.  |t Chemotherapy for primary central nervous system lymphoma /  |r Francois G. El Kamar and Lauren E. Abrey --  |g 29.  |t Chemotherapy of medulloblastoma /  |r Herbert B. Newton --  |g 30.  |t Chemotherapy of ependymoma /  |r Mark G. Malkin --  |g 31.  |t Chemotherapy for glioneuronal tumors /  |r Nimish Mohile and Jeffrey J. Raizer --  |g 32.  |t Chemotherapy of pineal parenchymal tumors /  |r Herbert B. Newton --  |g 33.  |t Current therapeutic management strategies for primary intracranial germ cell tumors /  |r Mark T. Jennings --  |g 34.  |t Chemotherapy of meningiomas /  |r Herbert B. Newton --  |g 35.  |t Chemotherapy for brain metastases /  |r Herbert B. Newton --  |g 36.  |t The role of chemotherapy in pediatric gliomas /  |r Lorna K. Fitzpatrick and Patricia K. Duffner. 
650 0 |a Brain  |x Cancer  |x Chemotherapy.  |0 http://id.loc.gov/authorities/subjects/sh2010008321 
650 1 2 |a Brain Neoplasms  |x drug therapy. 
650 0 |a Brain  |x Tumors  |x Chemotherapy. 
700 1 |a Newton, Herbert B.  |0 http://id.loc.gov/authorities/names/n2003130699  |1 http://viaf.org/viaf/4316790 
901 |a ToCBNA 
903 |a HeVa 
929 |a cat 
999 f f |i f9506e7f-9ac3-5a8d-91dd-09bc45c738ff  |s d4943392-a67f-5539-9f68-c352c229c7f3 
928 |t Library of Congress classification  |a RC280.B7 H36 2006  |l ASR  |c ASR-SciASR  |i 5001236 
927 |t Library of Congress classification  |a RC280.B7 H36 2006  |l ASR  |c ASR-SciASR  |e WIST  |e CRERAR  |b 75857171  |i 8009035